05 August 2017

Administrative Order No. 49-B s. 1988



October 24, 1988


ADMINISTRATIVE ORDER
No. 49–B series 1988


REVISED RULES AND REGULATIONS GOVERNING THE REGISTRATION, OPERATION AND MAINTENANCE OF CLINICAL LABORATORIES IN THE PHILIPPINES


Section 1
Title


These rules shall be known as “Revised Rules and Regulation governing the registration, operation and Maintenance of Clinical Laboratories in the Philippines.”


Section 2
Authority


These rules and regulations are issued to implement R.A. 4688 (Clinical Laboratory Law) consistent with E.O. 119 (Reorganization Act of the Ministry of Health).


Section 3
Purpose


These rules and regulations are promulgated to protect the health of the people by preventing the operation of sub–standard, improperly managed and inadequately supported clinical laboratories and by improving the quality of the performance of clinical laboratory examinations.


Section 4
Scope


1. These regulations shall apply to all entities performing the activities and functions of clinical laboratories which shall include the examination and analysis of any of all samples of human or animal tissues, fluids, secretions, excretions, radioactivity, or other material from the body for the determination of the existence of pathogenic organisms, pathologic processes of conditions in the person or animals from which such samples are obtained.

2. The following are not governed by these rules and regulations:

(a) Government laboratories doing routine or minimum laboratory examinations provided their services are declared as extensions of covered government regional or central laboratories.

(b) Laboratories being used solely for academic training and/or for purely research activities.

(c) Physicians doing only simple and routine examinations (routine hematology, urinalysis, fecalysis and gram staining) for their own patients only in their own clinics.


Section 5
Regulatory Authority


The Department of Health, through the Bureau of Research and Laboratories in the Office for Standards and Regulation, shall exercise the licensing and regulatory functions under these rules and regulations.


Section 6
Classification of Laboratories


1. For purpose of function, clinical laboratories may perform any of all of the following:

(a)   Clinical Pathology
(b)   Anatomic Pathology
(c)    Forensic Pathology

Clinical Pathology: includes clinical chemistry, hematology, chemistry, microbiology, parasitology, mycology, clinical microscopy, immunology and serology, immunohematology and blood banking, radioisotope analysis and laboratory endocrinology and similar disciplines

Forensic pathology: includes all medico–legal examinations

2. For purposes of institutional character, clinical laboratories, are either hospital laboratories or free–standing (non–hospital) laboratories. Hospital laboratories operate within a hospital; free standing laboratories operate on its own or part of an activity other than a hospital.

3. For purposes of services and level, clinical laboratories are either (1) primary; (2) secondary or (3) tertiary category depending on the range of laboratory examinations they perform and the presence of certain manpower, materials and facilities required. The services required for each respective category of laboratory shall be:

Primary Category

(a)   Routine hematology (CBC) – hemoglobin mass concentration, erythrocyte volume fraction (hematocrit), leukocyte number concentration (WBC) and leukocyte type number fraction (differential count)
(b)   Routine urinalysis
(c)    Routine fecalysis
(d)   Gram staining

Secondary Category

(a)   Routine hematology, urinalysis, fecalysis and gram staining
(b)   Routine chemistry – blood glucose, urea, urate, creatinine, cholesterol, total protein
(c)    Blood typing and cross matching

Tertiary Category

(a)   Routine hematology, urinalysis, fecalysis and gram staining
(b)   Routine chemistry
(c)    Blood typing and cross matching, donor selection and blood selection for transfusion
(d)   Special chemistry
(e)   Special hematology
(f)   Culture and sensitivity for bacteria

4. The permit issued shall clearly state or indicate the type (hospital or non–hospital, and Category (Primary, Secondary or Tertiary) of the clinical laboratory and other examinations permitted in addition to these enumerated as minimum requirements under the category approved.


Section 7
Licensing


No clinical laboratory may operate without a proper and valid issued by the Bureau of Research and Laboratories


Section 8
Licensing requirements
(Technical standards)


1. All clinical laboratories shall be required to demonstrate compliance with the following Technical Standards as requirements to licensing:

(a) Proper and competent management by a physician, licensed and duly registered with the Board of Medicine (PRC), qualified in laboratory medicine and duly authorized by the Undersecretary of Health for Standards and Regulation

(b) Adequate staffing by qualified and trained personnel with at least one (1) medical technologist registered with the Board of Medical Technology (PRC)

(c) Well ventilated, lighted, clean and safe physical space sufficient to accommodate its activities

(d) Necessary equipment, furniture, glassware, reagents and supplies to undertake the required services

2. The Bureau of Research and Laboratories shall evaluate compliance with such technical standards in accordance to minimum requirements for such category of laboratory or additional tests applied for as may be promulgated under these rules and regulations.


Section 9
Management of the Clinical Laboratory


1. Head of the Clinical Laboratory

The head is the person who assumed technical and administrative supervision and control of the activities in the laboratory.

For all categories of clinical laboratories, the head shall be a licensed physician certified by the Philippine Board of Pathology or both provided that:

(a) This shall be mandatory for all categories of free–standing clinical laboratories; all tertiary category hospital laboratories and for all secondary category hospital laboratories located in areas with the sufficient available pathologists.

(b) This shall be voluntary for all primary category hospital laboratories and secondary category of hospital laboratories in areas where pathologists are not sufficient. For those hospital laboratories unable to comply with the above requirements, they shall be headed by a licensed physician with training of at least 3 months in laboratory medicine, quality control and laboratory management and authorized by the Bureau of Research and Laboratories.

2. A laboratory providing clinical pathology and/or anatomic pathology service must have at least one pathologist certified in the subspecialty offered as head or associate.

3. A certified pathologist is authorized to manage/supervise or be an associate in not more than four (4) clinical laboratories/blood banks.

4. A physician under Section 9.1 paragraph 2 may be authorized to head only one (1) hospital laboratory.

5. Any change in the head during the period covered by a valid license shall be reported in writing to the Bureau of Research and Laboratories within 15 days after such change.


Section 10
Quality Control Tests


The Director of the Bureau of Research and Laboratories or his representative is hereby authorized to conduct such quality control tests as he deems appropriate or necessary for the administration or these regulations, for the control of operations and as criteria for the renewal of licenses.


Section 11
Reporting


All laboratory requests shall be considered as consultations between the requesting physician and the pathologist of the laboratory. As such all laboratory reports on various examinations of human specimens shall be construed as consultation reports and shall bear the name of the Pathologist or his associate. No person in clinical laboratory shall issue a report, orally or in writing whole or portions thereof without a directive from the pathologist or his authorized associate and only to the requesting physician or his authorized representative except in emergencies when the results may be released as authorized by the pathologist.


Section 12
Recording


An adequate and effective system of recording all requests and reports of all human specimens submitted to and examined in the laboratory should be maintained to include provisions for filing, storage and succession number in addition to patient’s personal information to prevent erroneous reporting and permit ready identification and retrieving. All requests and reports in clinical laboratory shall be kept on file for at least one (1) year provided the original report is on file in the patient’s medical records. Records of anatomic and forensic pathology should be kept permanently in the laboratory.


Section 13
Laboratory rates


The rates of laboratory fee to be charged by a clinical laboratory for examination shall be within the range of the usual rates prevailing at the time and particular place taking into consideration costs of production and quality control of various laboratory procedures. Professional services rendered to the patient in the performance of special procedures or examination shall be rated separately and not included in the laboratory rate.


Section 14
Basic license requirements


Any person, firm or corporation desiring to establish or operate and maintain a clinical laboratory shall submit to the Bureau of Research and Laboratories a sworn petition/application on the prescribed form containing among others the following data:

1. Name, citizenship and domicile of the Head of the Laboratory
2. Place, municipality and province where it is to be established.
3. Name of establishment
4. Name, citizenship and domicile of the owner
5. Scope of the nature of work to be undertaken
6. Statement duly notarized that applicant has complied with all business requirements under other existing laws or ordinances that are necessary in pursuance of the activity for which a license is herein applied for.

If the applicant is a partnership or corporation, the duly registered papers must be attached to the corresponding petition.


Section 15
Application of License


1. Application shall be filed by the owner or his duly authorized representative in a form “Petition to establish, operate and maintain a clinical laboratory” together with the “Information Sheet” to be filled by the physician – in – charge with the Bureau of Research and Laboratories for screening and approval.

2. Each petition shall be signed under oath and affirmation by the applicant or a person duly authorized to act for and in his behalf.

3. Upon receipt of said application together with the license fee, an inspector of the Bureau of Research and Laboratories shall inspect within 60 days the establishment and verify if the applicant has complied with the requirements prescribed in these regulations.

4. Any material or false statement in the application or failure to comply with the requirements may serve as basis for the Director of BRL to refuse recommending the issuance of a license to operate a clinical laboratory.


Section 16
License fees


1. A non–refundable fee shall be charged for every application for a license issued to open and operate a clinical laboratory both government and private.

2. A non–refundable fee is charged on application for renewal filed during three (3) months of each year.

3. All fees shall be payable to the Bureau of Research and Laboratories in accordance with the following schedule

For new licenses

            Primary category                    P 200.00         
            Secondary category                P 300.00
            Tertiary category                    P 500.00

For renewal of licenses

            Primary category                    P 100.00         
            Secondary category                P 150.00
            Tertiary category                    P 250.00

4. A penalty of P100.00 for late renewal shall be charged in addition to the renewal fee for all categories if the application is filed during the next two (2) months after March 31.

5. After the fifth month, un–renewed licenses shall be considered lapsed, and a new license shall be applied for.


Section 17
Inspection


Clinical laboratories and their facilities shall be subject to regular inspection and records made available to determine compliance with above regulations

1. Each license shall afford to give the Director of the Bureau of Research and Laboratories or his duly authorized representative at any reasonable time opportunity to inspect the premises and facilities wherein the laboratory examinations are being processed.

2. Each license shall make available to the Director of Bureau of Research and Laboratories or his duly authorized representative for inspection, records kept by him pursuant to those regulations.

3. The Director of the BRL or his representative may be assisted by experts from professional associations in such inspection.

4. Directors of Regional Health Offices, Provincial, City and Municipal Health Officers are hereby empowered to report the existence of unlicensed clinical laboratories or any private party performing laboratory examinations without proper permit or license and/or violations of these rules to the Bureau of Research and Laboratories.


Section 18
Issuance of License


1. The license will be issued, approved by the Undersecretary for Standards & Regulation if the application is found to be meritorious and the license fees duly paid, otherwise the same shall not be approved.

2. A provisional license may be granted to hospital laboratories in areas where there are insufficient pathologists while the Physician–in–charge is undergoing training as provided in Section 9. The provisional license is granted only once and valid for one (1) year.

(The validity for only one year shall be enforced 3 years after promulgation of the Revised Rules)


Section 19
Terms and Conditions of License


1. It is emphasized that the license is granted on the basis of specific circumstances, conditions and limitations established during the inspection and defined by the issuance of the license.

2. The license as herein granted as well as any right under the license shall not be assigned or otherwise transferred directly or indirectly to an unauthorized party

3. The owner or the owner’s representative of any clinical laboratory desiring to transfer a registered clinical laboratory to another place shall inform the Bureau of Research and Laboratories in writing within 15 days after transfer has been completed. The laboratory in its new location shall be subject to re–inspection and should comply with these rules.

4. Any change affecting the substantial conditions of the license to operate the laboratory shall likewise be reported within 15 day in writing by the persons concerned to the Bureau of Research and Laboratories for notation and approval. Failure to do so will cause the revocation of the license of the clinical laboratory.


Section 20
Exhibition of Certificate of Approval and License and the Rules and Regulations


The license of the clinical laboratory must be placed in a conspicuous place within the laboratory must likewise place his certificate of proficiency in the specialty. A copy of the rules and regulation should be readily available for guidance of all staff and personnel in the laboratory.


Section 21
Expiration


Each specific license shall expire on the last day of December of the year stated herein, including the authorization given to the head of the clinical laboratory


Section 22
Renewal


Application for renewal of license shall be filled during the 1st three (3) months of the year in accordance with Section 16. The Bureau of Research and Laboratories shall process application for license renewal immediately upon receipt thereof subject to inspection upon the discretion of the Director; provided, however, that such clinical laboratory may continue operation during the pendency of the final action on its application, unless otherwise revised or ordered by the Director, BRL to cease operation.


Section 23
Publication of Licensed Laboratories


1. A list of licensed laboratories according to their categories shall be published periodically and made available to any person, agency or organization for legitimate purposes.

2. The results of quality control tests shall likewise be published


Section 24
Modification and Revocation of Licenses


The terms and conditions of each license shall be subject to amendments or modification by means of amendments to these regulations, as the Secretary of Health may deem necessary. Any license may be revoked, suspended or modified in full or in part for any false statement in the application as revealed by the statement of the applicant, or as shown by the record of inspection or for a violation of, or failure to observe any of the terms and provisions of these regulations. Except in cases of willful, or repeated violations hereof or where public health interest or safety requires otherwise, no license shall be modified, suspended or revoked unless prior notice has been made and the corresponding investigations conducted.


Section 25
Violations


1. The license to operate a clinical laboratory may be suspended or revoked by the Undersecretary of Health for Standards and Regulation upon violation of R.A. 4688 or the rules and regulations issued in pursuance thereto or the commission or operating a clinical laboratory and the persons under their authority.

(a) Operation of a Clinical Laboratory without a certified Pathologist or qualified licensed physician authorized by the Undersecretary of Health or without employing a registered medical technologist or employing a person not registered as a medical technologist in such a position

(b) Change of ownership, location, Head of Laboratory or personnel without informing the Bureau of Research and Laboratories

(c) Refusal to allow inspection of the laboratory by the persons authorized by the Bureau of Research and Laboratories during reasonable hours;

(d) Refusal to perform tests on quality control samples required by the Bureau of Research and Laboratories

2. Any person who operates a clinical laboratory without the proper license from the Department of Health shall upon conviction be subject to imprisonment for not less than one (1) month but not more than (1) year or a fine of not less than P1,000.00 and not more than P5,000.00 or both such fine and imprisonment at the discretion of the court. Provided, however, that if the offender is a firm or corporation, the managing Head and/or owners thereof shall be liable to the penalty imposed herein.


Section 26
Investigation of Charges of Complaints


Upon filing of a complaint or charges duly sworn to by any person, interested party or corporation, against a clinical laboratory or any of its personnel of an approved laboratory have violated or are violating R.A. 4688 or the provisions of these regulations, the Undersecretary of Health for Standards and Regulation or his duly authorized representative(s) shall investigate the complaints or charges and verify in the laboratory concerned or any of its personnel is guilty of the charges. If upon investigation, a person or persons are found violating the provisions of R.A. 4688 or any of these regulations, the Undersecretary of Health for Standards and Regulation shall suspend for a definite or indefinite period of time or cancel or revoke the license of the laboratory and the authority of the offending person or persons, without prejudice to taking the case to judicial authorities for criminal action.


Section 27
Effectivity


These rules and regulations shall take effect 15 days after its publication in the Official Gazette, or in newspaper of general circulations and shall supersede all issuances inconsistent thereof.






No comments: